Study protocol to establish a prospective cohort for the study of phenotypic clusters, progression pathways, and outcomes of frailty and dependence: The CohorFES
Abstract
Frailty has become a major challenge for health systems, but it also presents a window of opportunity to fight disability through preventive strategies focused on the detection and treatment of frailty across all care settings. However, no systematic strategies for screening and early detection are currently available in clinical practice. This project aims to identify clinical and biological phenotypic clusters that drive progression through the different stages of frailty, and to describe the underlying mechanisms of the trajectories leading to disability and potential treatment interventions. In addition, the Frailty Trait Scale 5 (FTS5) will be validated as a practical tool for implementation in both primary care and hospital settings. A prospective, population-based cohort (CohorFES) will be established for frailty phenotyping. A CIBERFES Biobank will also be created to store blood and urine samples from CohorFES participants for future research. Demographic and clinical history data, anthropometric measurements, the PREDIMED questionnaire, peripheral blood biochemical variables, and metabolomics data will be collected at baseline and annually until participants develop frailty. Cluster partition models (k-means and hierarchical clustering) will be used to group individuals with similar deficits and characteristics (frailty phenotypes). Then, by using pre-established criteria (gap and silhouette), the proposed clustering solution (belonging to given clusters) will be…
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.